TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BRISTOL MYERS SQUIBB · Global biopharma company developing innovative medicines

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $80,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Health Issues

Lobbying related to pharmaceutical policy

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.